AstraZeneca PLC (BVMF:A1ZN34)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Oncology Revenue	23.93B	20.28B	17.15B
Oncology Revenue Growth	18.04%	18.26%	17.18%
BioPharmaceuticals: CVRM Revenue	12.86B	12.45B	10.59B
BioPharmaceuticals: CVRM Revenue Growth	3.31%	17.60%	15.20%
BioPharmaceuticals: R&I Revenue	8.48B	7.42B	6.11B
BioPharmaceuticals: R&I Revenue Growth	14.32%	21.43%	5.93%
BioPharmaceuticals V&I Revenue	1.20B	1.06B	1.01B
BioPharmaceuticals V&I Revenue Growth	13.80%	4.54%	-78.63%
Rare Disease Revenue	9.03B	8.67B	7.76B
Rare Disease Revenue Growth	4.17%	11.64%	10.08%
Other Medicines Revenue	1.00B	1.07B	1.18B
Other Medicines Revenue Growth	-6.62%	-8.76%	-27.63%
Collaboration Revenue	1.62B	3.14B	2.02B
Collaboration Revenue Growth	-48.26%	55.05%	49.45%
Revenue (Total)	58.13B	54.07B	45.81B
Revenue (Total) Growth	7.50%	18.04%	3.29%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
UK Revenue	-	4.74B	3.37B
UK Revenue Growth	-	40.74%	8.05%
Rest of Europe Revenue	-	11.70B	9.73B
Rest of Europe Revenue Growth	-	20.34%	9.16%
The Americas Revenue	-	24.99B	20.77B
The Americas Revenue Growth	-	20.31%	5.87%
Asia, Africa & Australasia Revenue	-	12.64B	11.95B
Asia, Africa & Australasia Revenue Growth	-	5.81%	-5.97%
Revenue (Total)	58.13B	54.07B	45.81B
Revenue (Total) Growth	7.50%	18.04%	3.29%

EBIT by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
UK Operating Profit	-	2.68B	665.00M
UK Operating Profit Growth	-	303.01%	-40.63%
Rest of Europe Operating Profit	-	5.92B	4.89B
Rest of Europe Operating Profit Growth	-	21.27%	65.87%
The Americas Operating Profit	-	423.00M	1.50B
The Americas Operating Profit Growth	-	-71.71%	-
Asia, Africa & Australasia Operating Profit	-	976.00M	1.15B
Asia, Africa & Australasia Operating Profit Growth	-	-14.98%	77.71%
Operating Income (Total)	12.80B	10.00B	8.19B
Operating Income (Total) Growth	27.97%	22.09%	118.07%

Capital Expenditures by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
UK Assets Acquired	582.00M	812.00M
UK Assets Acquired Growth	-28.32%	-64.71%
Rest of Europe Assets Acquired	2.23B	1.77B
Rest of Europe Assets Acquired Growth	25.71%	239.08%
The Americas Assets Acquired	3.93B	1.93B
The Americas Assets Acquired Growth	103.90%	357.25%
Asia, Africa & Australasia Assets Acquired	1.39B	117.00M
Asia, Africa & Australasia Assets Acquired Growth	1091.45%	129.41%

Updated Sep 30, 2025. Data Source: Fiscal.ai.